Alnylam Pharmaceuticals
Stephen Meninger, Pharm.D., is a highly experienced professional in the field of pharmacy, currently serving as a Medical Outcomes Science Liaison at Alnylam Pharmaceuticals since July 2018, with progressive roles in Value and Evidence Strategy. Prior experiences include positions at Sinai Health System as an Oncology and Hematology Extern, where a retrospective chart review was conducted, and at the Department of Defence as an extern in Managed Care Pharmacy, focusing on drug safety and cost-effectiveness. Additional roles include externships with Bioverativ, Optima Health, Pfizer, and the International Society for Pharmacoeconomics and Outcomes Research, providing a strong background in pharmacoeconomics, managed care, and patient outcomes. Stephen Meninger earned a Doctor of Pharmacy degree from the University of Maryland School of Pharmacy in 2018, following a Bachelor of Science in Food Science and Technology from the University of Maryland in 2013.
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
31 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.